(DAE) Daetwyl I - Ratings and Ratios

Dätwyler Holding AG is a Switzerland-based manufacturer specializing in high-precision elastomer components for critical applications across multiple industries. The company serves healthcare, mobility, connectors, general industrial, and food and beverage sectors globally, with operations spanning Europe, North America, South America, Australia, and Asia. Its products are integral to ensuring safety, efficiency, and reliability in applications ranging from medical devices to electric vehicles. Founded in 1915, Dätwyler operates as a subsidiary of Pema Holding AG and is headquartered in Altdorf, Switzerland.

The companys Healthcare Solutions segment focuses on advanced rubber components for drug delivery systems, including prefilled syringes, injection pens, and vial closures. It also supplies critical components for blood collection systems, IV administration sets, and diagnostic devices. These products are designed to meet stringent regulatory standards, ensuring patient safety and precise drug delivery. In the Industrial Solutions segment, Dätwyler provides sealing solutions for electric vehicle battery systems, combustion engine components, and industrial equipment. Its sealing technologies are used in oil and gas, aerospace, heavy machinery, and water treatment industries, addressing challenges related to durability, temperature resistance, and chemical compatibility.

As of the latest data, Dätwyler Holding AG trades under the ticker symbol DAE on the SIX Swiss Exchange. It is classified under the GICS sub-industry Trading Companies & Distributors. The companys market capitalization stands at CHF 1,923.04 million, reflecting its established presence in global markets. With a price-to-earnings (P/E) ratio of 64.59 and a forward P/E of 23.70, the stock is valued at a premium, likely due to its strong profitability and growth prospects. The price-to-book (P/B) ratio of 5.58 indicates significant intangible assets or high investor confidence. Its return on equity (RoE) of 41.47% highlights efficient profitability. The average trading volume over the past 20 days is 14,436 shares, with a last price of CHF 118.80. The stocks short-term trend is bearish, as the SMA 20 (CHF 115.08) is below the SMA 50 (CHF 119.38), while the SMA 200 (CHF 142.55) is significantly higher, suggesting a potential downtrend. The ATR of 4.85 indicates moderate volatility.

3-Month Forecast (Based on Technical and Fundamental Data): - Technical Outlook: The stock is currently in a bearish trend, with the SMA 20 below the SMA 50. However, the ATR of 4.85 suggests moderate volatility, which could lead to a potential breakout or breakdown. - Fundamental Outlook: With a forward P/E of 23.70 and strong RoE of 41.47%, the stock is positioned for long-term growth, supported by its dominance in high-margin industrial and healthcare markets. - Price Target: Based on the convergence of SMA 20 and SMA 50, the stock may consolidate between CHF 110 and CHF 125 over the next three months. A breakout above CHF 125 could signal a bullish reversal, while a drop below CHF 110 may indicate further downside.